Report of Foreign Issuer (6-k)
June 30 2016 - 4:26PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2016
Commission File Number: 001-34661
DEHAIER MEDICAL SYSTEMS LIMITED
Dehaier Medical Systems Limited
Room 501, 83 Fuxing Road
Haidian District, Beijing 100856
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Explanatory Note:
On June 28, 2016, Dehaier Medical Systems Limited (the
“Company”) entered into Amendment No.1 to Share Purchase Agreement (the “SPA”) with Hangzhou Liaison Interactive
Information Technology Co., Ltd. (“Liaison Interactive”), a publicly listed company on the Shenzhen Stock Exchange.
As previously announced, the Company entered into an SPA with Liaison Interactive. Pursuant to the SPA Liaison Interactive will
invest $20 million in the Company to purchase 11,111,111 restricted common shares (the “Shares”) of the Company at
a per-share price of $1.80. On June 6, 2016, the Company sold 620,414 of these shares to Liaison Interactive in a first closing
under the SPA. In accordance with Amendment No.1 to SPA, the closing date is extended from June 30, 2016 to September 30, 2016.
The foregoing summary of the terms of Amendment No.1 to SPA
is only a brief description of certain terms therein, does not purport to be a complete description of the rights and obligations
of the parties thereunder, and is qualified in its entirety by reference to Amendment No.1 to SPA that is filed as Exhibit 10.2
to this Current Report on Form 6-K and incorporated herein by reference.
Exhibits
The following document is filed herewith:
Exhibit
Number
|
|
Document
|
|
|
|
10.1
|
|
Share Purchase Agreement, dated April 28, 2016
|
10.2
|
|
Amendment No. 1 to Share Purchase Agreement, dated June 28,
2016
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
DEHAIER MEDICAL SYSTEMS LIMITED
|
|
|
|
|
|
June 30, 2016
|
By:
|
/s/ Ping Chen
|
|
|
|
Ping Chen
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer) and
|
|
|
|
Duly Authorized Officer
|
|
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024